Capital Advisors, Ltd. LLC Takeda Pharmaceutical CO LTD Transaction History
Capital Advisors, Ltd. LLC
- $793 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding TAK
# of Institutions
332Shares Held
68MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$174 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$61.4 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$55.9 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$45.2 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...